The present invention is directed to morpholinyl piperidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
本发明涉及一种抑制甘
氨酸转运蛋白GlyT1的
吗啡啶基
哌啶化合物,其在治疗与甘
氨酸能或谷
氨酸能神经递质失调相关的神经系统和精神障碍以及涉及甘
氨酸转运蛋白GlyT1的疾病中具有用处。